Reduction of Breast Hypertrophy by Means of Coelioscopique Surgery

Last updated: May 5, 2023
Sponsor: Groupe Hospitalier Nord-Essonne
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Reduction of breast hypertrophy by means of laparoscopic

Clinical Study ID

NCT05822115
2022-A01278-35
  • Ages > 18
  • Female
  • Accepts Healthy Volunteers

Study Summary

The objective of this interventional study is based on the hypothesis that coelioscopique surgery could be used to reduce breast hypertrophy.

This study can be expected to scientifically validate the use of laparoscopic surgery to obtain a clinical result in the context of reduction of medium volume breast hypertrophy.

Eligibility Criteria

Inclusion

Inclusion criteria :

  • Women over the age of 18.

  • Category 1 or 2 according to the Regnault classification.

  • C cup breast size or larger.

  • Areola "looks ahead" i.e. a distance between point A (at the top of the areola) at the median suprasternal point of approximately 16 cm to 24 cm.

  • Ptosis (distance between the lowest part of the breast and the submammary fold) of a maximum of 7cm (measured in a seated position).

  • Expected correction of half ptosis with decrease of 1 to 3 cup sizes.

  • Patient has good quality thick skin.

  • Social security scheme.

  • Patient requesting breast reduction.

  • Patient having signed the free and informed consent.

Non inclusion criteria :

  • Areola "look down"; point A more than 25 cm.

  • Ptosis greater than or equal to 8 cm.

  • Thin skin.

  • Smoker.

  • Patient under effects of anti-coagulant.

  • Patient participating in another clinical study.

  • Protected patient: adults under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision.

  • Pregnant, lactating woman.

Study Design

Total Participants: 5
Treatment Group(s): 1
Primary Treatment: Reduction of breast hypertrophy by means of laparoscopic
Phase:
Study Start date:
April 24, 2023
Estimated Completion Date:
September 30, 2024

Study Description

Breast reductions are common procedures. One of the main difficulties related to this surgery remains the healing, wide at the peri-areolar level, vertical at the sub-areolar level and in the sub-mammary fold. In addition, this intervention remains subject to the vagaries of hypertrophic or even keloidal healing, especially in young subjects.

On This study can be expected to scientifically validate the use of laparoscopic surgery to obtain a clinical result without scarring in the context of the reduction of medium volume breast hypertrophy.

Ultimately, the results of this study may serve as a basis for further research by proposing:

  • Prophylactic mastectomies and immediate breast reconstruction without lateral scar and with a less visible sub-breast scar.

  • A breast reduction in young patients before the skin undergoes the effects of the heaviness of the breasts.

Connect with a study center

  • Dr Eric DUNET

    Longjumeau, 91160
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.